...$37.6 million in cash plus the repayment of certain debt (see BioCentury, May 30, 2011). Edict Pharmaceuticals Pvt. Ltd....

...be accretive in 2013, is expected to close by year end. Terms were not disclosed. Edict Pharmaceuticals Pvt. Ltd....